# Ohio Breweries Challenge SB 56 THC Beverage Ban > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/ohio-thc-beverage-ban-challenge-sb56/ > **Published:** 2026-03-24T21:59:06-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:39:52-04:00 > **Clinical Summary:** Explore the Ohio THC beverage ban challenge under SB 56 and its impact on breweries and cannabis beverage market expansion. --- ✦ New CED Clinical Relevance #35 [Clinical Context](https://cedclinic.com/cannabis-hyperemesis-syndrome-treatment-insights-2026/) Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicyTHCIndustry Clinical Summary Ohio’s Senate Bill 56 prohibits the sale of THC-infused beverages, a restriction that local breweries are challenging as they seek to expand into the cannabis beverage market alongside their traditional alcohol operations. This regulatory action limits the product diversity available to consumers in states where cannabis is legal and affects small businesses attempting to diversify revenue streams in a competitive market. For clinicians, the restriction affects patient access to alternative cannabis delivery methods that some patients may prefer to smoking or traditional edibles, particularly those seeking dose-controlled, discreet consumption options. The legal challenge reflects ongoing tension between state-level cannabis regulation and business interests, which could influence how cannabis products are classified and distributed in the future. As cannabis medicine becomes increasingly integrated into clinical practice, restrictive beverage policies may inadvertently push patients toward less standardized or unregulated products. Clinicians should be aware of local cannabis product restrictions in their states, as these regulations directly impact what therapeutic options patients can legally access and what counseling points are relevant to individual treatment plans. Dr. Caplan’s Take “The prohibition on THC beverages in Ohio is clinically shortsighted because it eliminates a dosing method that many patients, particularly those with nausea or difficulty swallowing, find more reliable and predictable than smoking or edibles, and it does so based on regulatory caution rather than evidence of harm.” Clinical Perspective The push by Ohio breweries to overturn restrictions on THC-infused beverages highlights a growing tension between [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) momentum and regulatory caution in the beverage industry. While the economic interests of breweries are understandable, healthcare providers should recognize that THC beverages present distinct pharmacokinetic and safety considerations compared to traditional cannabis products or alcohol, including variable absorption rates, delayed onset of effects that may promote overconsumption, and potential risks of concurrent use with alcohol. Current evidence on the public health implications of THC beverages remains limited, particularly regarding dosing standardization, youth access prevention, and effects in vulnerable populations. Clinicians should stay informed about their state’s regulatory landscape, as these policies will shape patient exposure and inform counseling about cannabis product risks, and should be prepared to discuss with patients the lack of standardization in THC beverage potency and the importance of dose awareness. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Ohio+breweries+seek+to+overturn+SB+56+that+banned+THC+beverages+-+WKEF+%40drcaplan&url=https%3A%2F%2Fdayton247now.com%2Fnews%2Flocal%2Fohio-breweries-seek-to-overturn-sb-56-that-banned-thc-beverages)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fdayton247now.com%2Fnews%2Flocal%2Fohio-breweries-seek-to-overturn-sb-56-that-banned-thc-beverages)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Ohio+breweries+seek+to+overturn+SB+56+that+banned+THC+beverages+-+WKEF+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fdayton247now.com%2Fnews%2Flocal%2Fohio-breweries-seek-to-overturn-sb-56-that-banned-thc-beverages)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://dayton247now.com/news/local/ohio-breweries-seek-to-overturn-sb-56-that-banned-thc-beverages](https://dayton247now.com/news/local/ohio-breweries-seek-to-overturn-sb-56-that-banned-thc-beverages) Further Reading Evidence Watch[Alcohol quantity mediates the association between daily alcohol and cannabis co-use and alcohol consequences.](https://cedclinic.com/alcohol-cannabis-co-use-consequences-alcohol-quantity-mediation/) Cannabis Policy Wire[Policy Watch: 20 Regulatory Updates — March 20, 2026](https://cedclinic.com/drug-enforcement-controlled-substances-regulatory-policy-2026/) CED Clinic BlogTaxpayers to fund clear-up of huge illegal waste dumps [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [THC-infused drinks face new restrictions – Columbus – NBC4](https://cedclinic.com/thc-infused-beverages-restrictions-ohio/) An overview of new restrictions on THC-infused drinks in Columbus, highlighting regulatory challenges similar to Ohio's SB 56. [Read More](https://cedclinic.com/thc-infused-beverages-restrictions-ohio/) [DC Mayor Proposes To Let Medical Marijuana And Alcohol Companies Partner On THC Drinks](https://cedclinic.com/dc-cannabis-beverage-regulation-medical-marijuana-thc-drinks/) Insights into policy proposals allowing partnerships between marijuana and alcohol companies for THC beverages in DC. [Learn More](https://cedclinic.com/dc-cannabis-beverage-regulation-medical-marijuana-thc-drinks/) [Ohio's marijuana and hemp rules take effect – Spectrum News](https://cedclinic.com/ohio-marijuana-hemp-regulations/) Details on Ohio's marijuana and hemp regulations and their implications for cannabis businesses and consumers. [Explore Now](https://cedclinic.com/ohio-marijuana-hemp-regulations/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).